Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
3 hedge funds and large institutions have $2.55M invested in Abeona Therapeutics Inc Warrant in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
6% less capital invested
Capital invested by funds: $2.73M → $2.55M (-$176K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$18.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.49K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $2.17M | +$18.9K | +9,636 | +0.8% |
|
|
SFM
2
Soros Fund Management
New York
| $375K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $1K | +$1.49K | +762 | New |
|
ABEOW Hedge Fund Activity: Q3 2015 in Review
3 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q3 2015, worth a combined $2.55M — down 6.5% from $2.73M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ABEOW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $18.9K.
- 3 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q3 2015, up from 2 in Q2 2015.
- Funds reported $2.55M of Abeona Therapeutics Inc Warrant stock for Q3 2015, down 6.5% quarter-over-quarter.
- 1 fund opened new Abeona Therapeutics Inc Warrant positions in Q3 2015 and 0 closed out, a net change of +1 holder.
- The largest Abeona Therapeutics Inc Warrant buyer in Q3 2015 was Perceptive Advisors, an estimated $18.9K added.
Based on aggregated 13F filings for Q3 2015.